Industry & Business

CroíValve Raises €3.2 Million in Oversubscribed Funding Round

 Breaking News
  • Plastics Action Alliance Sets Targets to Achieve Sustainable Reduction in Use of Plastic Plastics Action Alliance, the recently formed group that comprises of 11 leading agricultural processing and food businesses in Ireland, has set out its key objectives. The industry leading group aims to significantly reducing the use of plastic packaging across its members’ operations. Formed at the end of 2018, the Plastics Action Alliance is a collaboration that [...]...
  • Nearly 45% of Irish Employees Say Their CEO Isn’t Visible to Staff Nearly 45% of employees say that their CEO isn’t visible to staff and discourages them from dropping into their office, according to a new report published by Dublin-based communications agency PR360. Almost 30% of CEOs rarely or never socialise with staff, and a third of employees say that their CEO doesn’t even know their name. The PR360 [...]...
  • SEAI Leads €2.6 Million European Project to Unlock Potential of Ocean Energy The Sustainable Energy Authority of Ireland (SEAI) is leading a new pan-European project, Ocean Power Innovation Network (OPIN), which aims to accelerate the development of the ocean energy sector. With a three year budget of €2.6 million, SEAI will partner with organisations in the UK, Belgium, France, Germany and the Netherlands to explore ways to [...]...
  • The UK National Construction Expo – The Arena MK, Milton Keynes – 1st May 2019 The UK National Construction Expo is being held at the Arena MK, Milton Keynes in England on Wednesday, 1st May 2019. Although British construction activity overall has slowed, chiefly due to businesses continuing to postpone major building projects due to Brexit uncertainty, which is impacting the commercial construction and civil engineering sectors, house building remains buoyant. Of [...]...
  • Skillnet Ireland Announces New Funding For Businesses to Upskill Employees Skillnet Ireland, the national agency responsible for the promotion and facilitation of workforce learning in Ireland has announced up to €2 million worth of funding which is being made available to businesses, industry bodies or enterprise groups who wish to establish a new Skillnet Learning Network. Skillnet Networks are enterprise-led learning networks, working to support businesses, industry [...]...

CroíValve Raises €3.2 Million in Oversubscribed Funding Round

CroíValve Raises €3.2 Million in Oversubscribed Funding Round
April 02
12:01 2019

CroíValve, a medtech start-up providing a safe and effective treatment for tricuspid regurgitation, has secured €3.2 million in an oversubscribed seed financing round. The round was led by the HBAN (Halo Business Angel Network) MedTech and Irrus Syndicates, alongside Atlantic Bridge University Fund, Enterprise Ireland, SOSV and a group of cardiologists who see the treatment’s transformative potential. The funding will support the continued development of CroíValve’s innovative technology.

CroíValve, a spinout from the Trinity Centre for Bioengineering, has developed a minimally invasive treatment for tricuspid regurgitation (TR). The heart condition occurs when the leaflets or cusps of the tricuspid valve – the valve separating the heart’s right ventricle and right atrium – fail to close properly due to dilation of the right heart, allowing blood to leak backwards into the right atrium. This causes further expansion, and eventually failure, of the right side of the heart. It is a severe cardiac disease with progressive symptoms including fatigue, fluid retention leading to abdominal and ankle swelling, liver and kidney failure, and death.

As the vast majority of patients are elderly and too frail for open-heart surgery, the only option available to them is medication that removes the excess fluid but does not cure the condition. CroíValve’s innovative technology specifically addresses the challenges associated with tricuspid heart valve disease. The device is delivered through the heart’s blood vessels and seals the gap between the native valve leaflets, therefore restoring the heart’s function and preventing regurgitation. The device is held in place with a unique anchoring system that removes the need for potentially traumatic anchoring into the right heart. The procedure is safe, simple and effective. With over half-a-million new cases annually in the US and EU alone, it is a significant unmet need and market opportunity.

Dr Lucy O’Keeffe, CEO, CroíValve, said: “To date, all treatment options are either too invasive or merely symptom management. CroíValve was established from a desire to bring a new, safe treatment option that can change and save lives. We welcome the investors’ support in accelerating our development efforts and look forward to working together to bring this exciting technology to patients. In doing so we are currently building our team, particularly in the area of R&D, and by year-end 2019 we will have grown to a company of 10. As part of this expansion, we are delighted to welcome Dr Ivan Vesely as our CTO, and the extensive knowledge that he brings. Additionally, we have established a great board, with Bernard Collins, one of our investors from the HBAN MedTech syndicate, bringing vast experience as chairman.”

Dr. Martin Quinn, CMO, CroíValve, said: “The CroíValve technology will revolutionise the treatment of patients with severe tricuspid incompetence. It is extremely easy and safe to use and can be implanted without the need for general anaesthesia.”

The funding round was led by 48 angel investors from HBAN, the all-island organisation responsible for the promotion of business angel investment, and an initiative of Enterprise Ireland, InterTradeIreland and Invest Northern Ireland. It is the largest ever number of HBAN members to contribute to one funding round and together they invested €1.5 million in the company.

Bernard Collins, CroíValve Chairman and HBAN MedTech Syndicate member, said: “As angel investors, we are not just providing capital to CroíValve, but also knowledge of, and contacts within, the medtech sector. This will help to open doors for CroíValve and enable the company to scale and commercialise its device. As chairman and an investor, I am extremely excited to be involved in this game-changing company dedicated to transforming the way tricuspid regurgitation is treated.”

CAPTION:

Announcing that CroíValve has secured €3.2 million in an oversubscribed seed financing round are (l-r): Helen Ryan, Senior Advisor, Atlantic Bridge; Bernard Collins, CroíValve Chairman and HBAN MedTech Syndicate member; and Dr. Lucy O’Keefe, CEO, CroíValve.

About Author

admin

admin

Related Articles

New Subscriber

Subscribe Here



Advertisements






















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4